SCHEDULE: enVVeno Medical Corp: Investors Exit Holdings

Braeden Lichti and Northstrive Fund II LP have completed their exit from enVVeno Medical Corp, selling all shares and filing a final amendment to their Schedule 13D.

Summary

• Braeden Lichti and Northstrive Fund II LP have filed a final amendment to their Schedule 13D, indicating they have sold all of their previously owned shares of enVVeno Medical Corp's common stock.
• Braeden Lichti sold his shares on September 11, 2026.
• Northstrive Fund II LP sold its shares between September 11, 2026, and September 14, 2026.
• Following these sales, neither Braeden Lichti nor Northstrive Fund II LP beneficially own any shares of enVVeno Medical Corp.
• This filing serves as an exit filing for both parties.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this as a negative sentiment due to the complete divestment of shares by the reporting persons, indicating a lack of confidence or strategic shift away from the company.

Negatives

• Complete divestment of shares by significant reporting persons (Braeden Lichti and Northstrive Fund II LP).
• The reporting persons no longer hold any beneficial ownership in enVVeno Medical Corp.

Future Outlook

No forward-looking statements or guidance are provided in this filing, as it pertains to the cessation of beneficial ownership.

Management Comments

• Braeden Lichti is the Manager of Northstrive Fund II LP.
• Braeden Lichti is the Chief Executive Officer of Northstrive Companies Inc.

Industry Context

StockSavvy.ai notes that significant share sales by investors, especially those filing Schedule 13Ds, can signal a lack of confidence in the company's future prospects or a strategic reallocation of capital. This exit filing by Braeden Lichti and Northstrive Fund II LP suggests a definitive move away from enVVeno Medical Corp.

Stakeholder Impact

• Shareholders may perceive this divestment as a negative signal, potentially impacting the stock price.
• The market may interpret this as a lack of confidence from significant former holders.

Next Steps

• The reporting persons have completed their divestment and filed this exit statement.

Key Dates

Recommendation

While the complete exit of significant holders is a negative signal, the filing itself is an administrative update confirming a past event. Without further information on the reasons for the sale or the company's current operational status, a 'hold' recommendation is prudent, advising investors to monitor the company's performance independently.

Keywords

enVVeno Medical Corp, Schedule 13D, Exit Filing, Divestment, Shareholder